HTB homepage • Conference reports • Articles by subject • Subscribe August 2021 Contents Editorial HTB: no. 8 – plus HIV and COVID-19 (1 August 2021) Conference reports 11th IAS Conference on HIV Science (IAS 2021) IAS 2021: lenacapavir studies show impressive results in naive, extensive drug resistance and potential as PrEP IAS 2021: HIV pipeline drugs: CAB/RPV LA, fostemsavir, paediatric dolutegravir, lenacapavir, islatravir, MK-8507 and albuvirtide IAS 2021: Proving efficacy of next generation PrEP: counterfactual controls in lenacapavir and islatravir studies IAS 2021: WHO report links HIV to 30% increased mortality from COVID-19: based on South African data IAS 2021: New demands for better transgender heath care: No data no more 13th International Workshop on HIV Paediatrics 2021 Dolutegravir superior to standard-of-care in young children: results from the ODYSSEY trial Coinfections and complications UK Biobank study finds no link between CMV and cardiovascular disease: HIV not included HIV prevention and transmission Phase 1 HIV mosaic vaccine study launched at Oxford university On the web Ending the HIV epidemic (EHE) in the US COVID-19: HIV and COVID-19 coinfection Antibody responses to Pfizer vaccine in HIV positive people with high CD4 counts COVID-19: vaccine research Third dose of mRNA vaccine improves antibody responses in kidney transplant recipients US CDC recommends third vaccine dose in some groups Pfizer plans for third dose: questions over population need? Efficacy of Oxford/AZ and Pfizer vaccines against Delta variant in the UK Results from Novavax phase 3 study in the UK WHO approves Chinese vaccines for emergency use Selected other vaccine studies Efficacy of Chinese CoronaVac vaccine in Chile national programme COVID-19: investigational drugs NHS supports selected use of inhaled budesonide for COVID-19 in people at risk of severe events Reviews of ivermectin for COVID-19: no evidence of benefit from RCTs RCT shows no impact of azithromycin in reducing symptoms of mild COVID-19 COVID-19: pathogenesis Variation in ACE2 levels are not related to outcomes from COVID-19 PDFs HTB: no. 8 – plus HIV and COVID-19 (1 August 2021) HTB homepage • Conference reports • Articles by subject • Subscribe
